TriangleNCT02470897 · OUTCOME
Disease-free Survival as Measured by the Phoenix Definition
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- MEDIAN
- Unit
- months
- Interval / dispersion
- Inter-Quartile Range
- Time frame
- Up to 5 years
What was measured
Disease-free failure events include local progression, distant progression biochemical failure as defined by the Radiation Therapy Oncology Group (RTOG) Phoenix definition, and death from any cause. Participants will be considered to be without biochemical recurrence if either the PSA is still declining or the prostate-specific antigen (PSA) has not risen above its nadir by ≥ 2 ng/ml (Phoenix definition).
Groups in this outcome
Arm A (Moderate Dose SBRT With SIB)
Patients undergo 5 fractions of moderate dose SBRT with SIB every other day for 10 days following urethral-sparing IMRT planning. SBRT: 8.0Gy escalated dose Radiation Therapy Treatment Planning and Simulation: Undergo urethral-sparing IMRT planning SBRT: Undergo moderate dose SBRT with SIB
Arm B (Uniform Dose SBRT)
Patients undergo 5 fractions of uniform dose SBRT every other day for 10 days following urethral-sparing IMRT planning. SBRT: 7.5Gy conventional dose Radiation Therapy Treatment Planning and Simulation: Undergo urethral-sparing IMRT planning SBRT: Undergo uniform dose SBRT
| Group | Source count |
|---|---|
| Arm A (Moderate Dose SBRT With SIB) | 100 |
| Arm B (Uniform Dose SBRT) | 15 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Arm A (Moderate Dose SBRT With SIB) | NA | Not reported | NA | NA | insufficient number of participants with events |
| Arm B (Uniform Dose SBRT) | NA | Not reported | NA | NA | insufficient number of participants with events |
Complete source fields
- classes
- categories
- measurements
- comment
- insufficient number of participants with events
- group Id
- OG000
- lower Limit
- NA
- upper Limit
- NA
- value
- NA
- comment
- insufficient number of participants with events
- group Id
- OG001
- lower Limit
- NA
- upper Limit
- NA
- value
- NA
- denoms
- counts
- group Id
- OG000
- value
- 100
- group Id
- OG001
- value
- 15
- units
- Participants
- description
- Disease-free failure events include local progression, distant progression biochemical failure as defined by the Radiation Therapy Oncology Group (RTOG) Phoenix definition, and death from any cause. Participants will be considered to be without biochemical recurrence if either the PSA is still declining or the prostate-specific antigen (PSA) has not risen above its nadir by ≥ 2 ng/ml (Phoenix definition).
- dispersion Type
- Inter-Quartile Range
- groups
- description
- Patients undergo 5 fractions of moderate dose SBRT with SIB every other day for 10 days following urethral-sparing IMRT planning. SBRT: 8.0Gy escalated dose Radiation Therapy Treatment Planning and Simulation: Undergo urethral-sparing IMRT planning SBRT: Undergo moderate dose SBRT with SIB
- id
- OG000
- title
- Arm A (Moderate Dose SBRT With SIB)
- description
- Patients undergo 5 fractions of uniform dose SBRT every other day for 10 days following urethral-sparing IMRT planning. SBRT: 7.5Gy conventional dose Radiation Therapy Treatment Planning and Simulation: Undergo urethral-sparing IMRT planning SBRT: Undergo uniform dose SBRT
- id
- OG001
- title
- Arm B (Uniform Dose SBRT)
- param Type
- MEDIAN
- reporting Status
- POSTED
- time Frame
- Up to 5 years
- title
- Disease-free Survival as Measured by the Phoenix Definition
- type
- PRIMARY
- unit Of Measure
- months
Download exact source JSON → · Snapshot ctgov-results-d643ffaf417bcef6d45eb5e0
Preserved source evidence · Not medical advice